NCT00098579 2013-03-19Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By SurgeryNational Cancer Institute (NCI)Phase 1 Completed36 enrolled